On-demand webinar: Leveraging advances in predesigned synthetic sgRNA for highly functional and specific CRISPR-Cas9 gene knockout
Posted: 11 September 2020 | Horizon Discovery | No comments yet
This webinar explains how synthetic guide RNAs are stable, eliminate cloning and sequencing steps, and avoid innate immune responses and cytotoxicity.
This on-demand webinar explains how synthetic guide RNAs are amenable to chemical modifications for increased stability, eliminate time-consuming steps of cloning and sequencing, and do not provoke the inherent immune response and cytotoxicity of in vitro transcribed guide RNAs. They can be readily delivered into cells for high-throughput arrayed screening applications and expand the types of phenotypic readouts to high-content and morphology-based assays.
Related topics
Assays, Bioengineering, Biomarkers, Biopharmaceuticals, Cell Cultures, Disease Research, Genome Editing, Hit-to-Lead, Immunology, Personalised Medicine, Regenerative Medicine, Screening, Stem Cells, Targets
Related organisations
Horizon Discovery